Cancer: NICE (symptom based)- what s new November 2016
|
|
- Grant Bishop
- 5 years ago
- Views:
Transcription
1 Cancer: NICE (symptom based)- what s new November 2016 Dr Katy Gardner, Dr Cathy Hubbert, Macmillan GP Cancer Leads, Liverpool CCG See stalls for more information and local pathways (Cheshire & Merseyside)
2 COULD IT BE CANCER? Now 3% threshold
3 HISTORY AND EXAM INVESTIGATE REFER REVIEW SAFETY NET
4 SYMPTOMS: NICE recognises that: Patients present with symptoms /signs or combinations: BMJ /CRUK charts
5 Non site specific symptoms of concern: WEIGHT LOSS: many cancers APPETITE LOSS: remember lung and ovary DVT is back! Several cancers include: urogenital, breast, colorectal, lung, pancreas FATIGUE: FBC, Ca125, CXR -(40+ ever smoked/ asbestos)
6 INVESTIGATIONS: some highlights FBC for PLATELETS, WBC, ANAEMIA IRON STUDIES ELECTROPHORESIS and BJP Ca 125 CALCIUM (myeloma) GLUCOSE ( pancreas, endometrial) ULTRASOUND/CT URINE visible/non visible haematuria *Recurrent infection can be significant
7 RAISED PLATELETS: in up to 30% of some cancers: Lung: >40 consider CXR Upper GI: >55 naus/vom/wt loss/ dyspepsia/abd pain: consider OGD Endometrial: >55 haematuria/vag disch: consider US Consider age/other risks
8 Iron Deficiency Anaemia (IDA) New importance in NICE.. No cut-off threshold 60+ IDA: Refer 2ww <50 IDA + rectal bleeding: consider ref to lower GI >55 anaemia +abdo pain: consider OGD (upper GI cancer)
9 Ix for Myeloma Persistent bone pain: esp back pain, or unexplained fracture: do FBC, ESR, Ca 60+ with hypercalcaemia/ WBC: do electrophoresis and BJP within 48hr As well as myeloma think about bony secondaries
10 When to check CA125 (Females) Abdo/pelvic pain/distention (persistent) age 50 IBS symptoms age 50 Change in bowel symptoms Urine urgency (persistent) age 50 Examine patient! NICE: Do CA125/US BUT locally: do Ca125 first: If Ca125, arrange US abdo/pelvis: mark URGENT suspected ovarian cancer. Put CA125 result on form. Will have US within 2 weeks
11 When to request US CONSIDER -Routine: F 55, Vaginal discharge (new/ platelets/haematuria (endometrial) F 55 haematuria + anaemia or platelets or glucose (endomterial) (AS WELL AS 2ww urology if visible haematiuria) M Unexplained or persistent testicular symptoms (BUT possible urgent!) URGENT: unexplained lump increasing in size (sarcoma)
12 When to request urgent CXR OFFER: 40 ever smoked +1 unexplained symptom (2 if never smoked): Cough, fatigue, SOB, chest pain, weight loss, appetite loss Asbestos exposure + 1 of above CONSIDER: >40 persistent/ recurrent chest infection, finger clubbing, LN: supraclavicular or cervical, pleural disease, thrombocytosis (Suspicious CXR: straight to CT pathway in Liverpool )
13 When to request urgent OGD Dysphagia 55 + weight loss + one of : Upper abdominal pain/ reflux/ dyspepsia CONSIDER if Upper abdominal mass consistent with stomach cancer (BUT consider CT ) See stalls for local pathways
14 When to arrange routine OGD CONSIDER if >55 and: Dyspepsia: treatment resistant Anaemia (normo/micro) + upper abdominal pain Nausea or vomiting + any of: weight loss /reflux/dyspepsia/upper abdo pain Raised platelets + naus vom wt loss /reflux/dyspepsia/upper abdo pain Hematemesis (use clinical judgment!)
15 When to request urgent CT: (think pancreas) CONSIDER: 60 + weight loss + one of: diarrhoea, constipation, back pain, abdominal pain, nausea, vomiting, new onset diabetes. Straight to CT pathways at Aintree & RLBUHT- and St Helens and Knowsley (for weight loss/ vague symptoms that don t fit 2ww see handout)
16 Faecal Occult Blood FOB in NICE for: 50 unexplained abdo pain or weight loss < 60 change in bowel habit or IDA >60 with anaemia not nec IDA BUT may not be available locally -debate ongoing. So what can we do? Examine / do bloods. IDA -- to IDA clinic if available or colorectal Wt loss - see CT or does any other pathway fit? If you think FOB and sx don t fit other urgent pathways-consider 2 ww GI referral.
17 Weight loss (recap) plus: Ever smoked/ h/o asbestos- cough/ fatigue/ SOB / chest pain/ appetite loss- CXR Abdo pain/ rectal bleeding- lower GI Upper abdo pain/ reflux/ dyspepsia or raised platelets/ nausea/ vomit- OGD Diarrhoea/ abdo/ back pain/ n/ v/ constipation/ new onset DM- CT Splenomegaly/ lymphadenopathy- Haematology F esp 50+ Ca125- ovarian
18 Fatigue (recap) plus: 40 or > Ever smoked/h/o asbestos/ cogh/ weight loss/sob/ chest pain/ appetite loss CXR* Persistent unexplained and age FBC within 48 hrs F 50 or > wt loss, change in bowel habit- Ca 125 Remember to examine the patient! *can be normal in up to 20% lung Ca think CT
19 Children & Young Adults Refer within 48 hr: Abdo mass /enlarged abdo organ/ unexplained visible haematuria Refer within 2w: absent red reflex FBC (48h): unexplained bruising/bleeding/pallor/lymphadenopathy/ fever/ infection/ fatigue US (48h): lump unexplained/ increasing X ray (48h): bone pain/ swelling Consider Parental concern 19
20 Tumour Specific Pathways Most = broader e.g Colorectal o 50y: unexplained rectal bleed o 40y: weight loss and abdo pain Clinical judgement key encourage GPs to refer, consider, investigate Controversial: ENT clinicians keep persistent sore throat etc. and remember HPV Some Oral lesions advises dentist but not all have one so refer 2ry care
21 Tumour Specific Pathways Useful Tools -worth CPD time to familiarise and know where to look! Eg Macmillan, GP Update, BMJ/CRUK charts GP UpdateCancer course
22
23 NICE emphasises Communicate: Patient preferences Potential risk and benefits Explain: referred to cancer service (but most referred do not have cancer) Inform on possible diagnosis (benign & malignant) Where, when, what, who? Further information/written, support, language Patient friendly letter/ CRUK leaflet (see stalls)
24 NICE emphasises: Safetynet Responsibility for reviewing/acting on results of investigation. Keep pt under review Or: Explicitly pass on responsibility. Awareness false negatives (CXR and FOB) New symptom, patient concerned, recurs, persists or worsens. HAVE YOU GOT FIALSAFE SYSTESM IN PLACE?
25 LOCAL INITIATIVES include Colorectal Clinics AO advice pilot Direct to CT Brain MRI Ovarian 50+ pathway See stalls! Ask CRUK team
26 Acute Oncology- Is it Cancer? advice see stalls for full algorithm
27 Direct to CT Aintree/ RLBUHT(similar New NICE Plus Patient has symptoms which give GP high index of suspicion of cancer but History/examine/ usual investigations don t fit 2ww.. Any age pathway Whitson) See Handouts. NB on local Trusts
28 Brain -Direct to MR coming soon Adults with progressive, sub-acute loss of CNS function* NICE says do MRI New referral forms for Walton Neuro being prepared. (Criteria/contraindications: see CCG websites) *Now: If Direct MRI not available refer 2ww or ring Walton helpline (available through switchboard)
29 Ovarian pathway: F age 50+ Cheshire and Merseyside-see stalls
30 Risk assessment tools: (Macmillan/Qcancer. Now in Emis) For common cancers: Estimates lifetime risk of cancer Based on multiple risk factors *Does not align perfectly with NICE Down to clinical judgements/patient preferences We feel: Useful if person presents with symptoms and you are thinking cancer
31 Do 3 things! Examples 1. Safety-netting: ensure systems in place 2. RCGP/national cancer audit 3. SEA:
32 For more information contact your primary care cancer team : Dr Katy Gardner katyagardner@btinternet.com Dr Cathy Hubbert cathy.hubbert@livgp.nhs.uk Dr Debbie Harvey Debbie.Harvey@southseftonccg.nhs.uk Dr Paul Morris Paul.Morris@knowsleyccg.nhs.uk Dr Graeme Allan graeme.allan@talk21.com Dr Hong Tseung hong.tseung@nhs.net Tomas Edge (CRUK) tomas.edge@cancer.org.uk Louise Roberts (CRUK) louise.roberts@cancer.org.uk
Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives
Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives Dr. Louise Merriman GP Clinical Lead for South Yorkshire, Bassetlaw and Derbyshire Cancer Alliance Topics to be covered
More informationIntroduction. Please note the toolkit aims to share learning and good practice, but it is, of necessity, brief in nature.
July 2015 edition Introduction The Rapid Referral guidance toolkit has been produced by Macmillan Cancer Support. It contains the NICE referral guidelines for suspected cancer (2015 update) with additional
More informationAchieving earlier diagnosis of cancer in Lincolnshire. Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018
Achieving earlier diagnosis of cancer in Lincolnshire Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018 The state of Lincolnshire Cancer Care Lincolnshire: The worst part of the country
More informationNICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios
NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios How to use the case scenarios The case scenarios can be used in a training
More informationFIT for symptomatic patients. Facilitator name
FIT for symptomatic patients Facilitator name Context colorectal cancer Colorectal cancer in the UK 41,804 new cases in 2015 15,903 deaths in 2014 Fourth most common cancer Second most common cause of
More informationEast Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018
East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018 GP INTIATIED DIAGNOSITCS USS Gall Bladder or Liver Fast-track ultrasound to assess for gall bladder or liver
More informationPATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease
PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease Refer back to original requester with this paperwork and review previous
More informationSCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018
SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 Dr Peter Hutchison, Chair of Review Group WHAT & WHY? Scottish Cancer Referral Guidelines 2014 Scottish Primary Care Cancer Group identified need for some
More informationGreater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres
Greater Manchester Commissioning Hub: Cancer Programme The ACE Programme Wave 2 Multidisciplinary Diagnostic Centres Background / Context GM Pilot focuses on 2 areas of Greater Manchester: Oldham South
More informationInformation Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West
Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West The South West Cancer Alliances have been awarded transformation funding to provide access to
More informationCancer Care Kenya Notes for General Practioners:
Cancer Care Kenya Notes for General Practioners: Site specific symptoms for detecting cancers at an early stage is given below. Please refer patients for detailed work up. 1. Brain /CNS tumors: Sub acute
More informationHaematological Cancer Suspected (Adults & Children)
Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: https://www.nice.org.uk/guidance/ng47 Patient of any age presents with symptoms of possible haematological cancer If 60 years
More informationQcancer: symptom based approach to early diagnosis of cancer. Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd
+ Qcancer: symptom based approach to early diagnosis of cancer Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd Acknowledgements Co-authors QResearch database EMIS & contributing
More informationCancer of Unknown Primary Service
Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT
More informationLung Cancer - Suspected
Lung Cancer - Suspected Shared Decision Making Lung Cancer: http://www.enhertsccg.nhs.uk/ Patient presents with abnormal CXR Lung cancer - clinical presentation History and Examination Incidental finding
More informationFREEDOM OF INFORMATION ACT 2000 Dudley CCG - Info re Prostate Cancer refferals etc.: RFI0430
Freedom of Information Team Dudley CCG Response by email 2nd Floor, Brierley Hill Health and Social Care Centre Venture Way Brierley Hill DY5 1RU 26 May 2016 FREEDOM OF INFMATION ACT 2000 Dudley CCG -
More informationClinical Biochemistry Department City Hospital
Cancer Biochemistry and Tumour Markers Clinical Biochemistry Department City Hospital In this lecture Cancer basics Definition of Tumour Marker (TM) What is the perfect TM? History of TMs Examples of TMs
More informationUpdate on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree
Update on Management of Malignant Spinal Cord Compression Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Current Guidelines The symptoms of MSCC may be subtle and therefore careful
More informationThis information explains the advice about suspected cancer that is set out in NICE guideline NG12.
Recognising, investigating and referring people with symptoms of suspected cancer Information for the public Published: 25 June 2015 nice.org.uk About this information NICE guidelines provide advice on
More informationPRIORITIES AND CLINICAL EFFECTIVENESS FORUM
PRIORITIES AND CLINICAL EFFECTIVENESS FORUM CANCER - GUIDELINES FOR URGENT REFERRAL OF PATIENTS WITH These guidelines are intended as a quick reference for GPs to ensure appropriate referral of those patients
More informationDr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer Alliance
FIT for symptomatic patients Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer Alliance AIMS Review National advice Consider
More informationTransforming Cancer Services for London
Programme Director Paul Roche Status Draft Owner Laura Boyd Version 0.4 Author Jennifer Layburn Date 15/05/13 Transforming Cancer Services for London Best Practice Commissioning Pathway for the early detection
More informationBronchiectasis in Adults - Suspected
Bronchiectasis in Adults - Suspected Clinical symptoms which may indicate bronchiectasis for patients Take full respiratory history including presenting symptoms, past medical & family history Factors
More informationGP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012
GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012 Version Control This is a controlled document please destroy all previous versions on receipt of a new version. Date
More informationValue of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis
Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis BMJ 2010;340:c1269 doi:10.1136/bmj.c1269 Mr DC 62 year old man Borderline anaemia
More informationInformation for families with a slightly increased risk of bowel cancer. Family History of Bowel Cancer
Information for families with a slightly increased risk of bowel cancer Family History of Bowel Cancer How common is bowel cancer? Bowel cancer is the 3rd most common cancer in the UK. 1 in 20 people develop
More informationCancer of Unknown Primary (CUP) Protocol
1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date
More informationLung Cancer and the Cancer Alliance DR JAMES RAMSAY
Lung Cancer and the Cancer Alliance DR JAMES RAMSAY Background Lung cancer is the second commonest cancer in the UK (37,000 new cases in England each year). Commonest cause of cancer death (28,500 people
More informationPalliative Care Emergencies
Palliative Care Emergencies LAURA BARNFIELD What might constitute an emergency in Palliative Care? 1 Palliative Care Emergencies Major haemorrhage Metastatic Spinal Cord Compression (MSCC) Superior Vena
More informationSouth Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance
South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance Patient Details: Patient Name Address DOB Home Tel. No. Mobile Tel. No. Preferred Tel. No. Main Spoken Language Transport needed? Registered
More informationThe York Faecal Calprotectin Care Pathway for use in primary care. James Turvill
The York Faecal Calprotectin Care Pathway for use in primary care James Turvill NICE guidance: dg11 Faecal calprotectin (FC) testing as an option in adults with recent onset of lower gastrointestinal symptoms
More informationCancer Cascade Workshop. DoubleTree by Hilton, Bristol 11 th May 2017
DoubleTree by Hilton, Bristol 11 th May 2017 Dr Richard Roope RCGP and Cancer Research UK Cancer Clinical Champion Senior Clinical Advisor Cancer Research UK What s new? Cancer Cascade Workshop What s
More informationThere are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway.
December 2015 CONTENTS Contents... 2 1 Introduction... 3 2 Case for Change... 3 3 Evidence... 3 3.1 National and regional policy... 3 3.2 Local audit... 4 4 Supporting Work Initiatives... 5 4.1 Identification
More informationChemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...
Coping, now your chemotherapy is finishing [ovarian cancer] Patient Information Series PI 41a East and North Hertfordshire NHS Trust 2 Contacts Chemotherapy Suite:... 020 3826 2236 [Mon - Fri, 8.00am -
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Specialist Sarcoma Multi Disciplinary Team for Suspected Bone Sarcoma Version History Version Date Brief Summary
More informationEarly Diagnosis: Serious but non-specific symptom pathway
Early Diagnosis: Serious but non-specific symptom pathway Lily Megaw Becky Gokce Karen Fitzgerald Geraint Jones Luigi de Michele Arun Takhar Introduction Lily Megaw This is a five year programme Based
More informationTHAMES VALLEY AUDIT OF PATIENTS DIAGNOSED WITH CANCER FOLLOWING AN EMERGENCY PRESENTATION
THAMES VALLEY AUDIT OF PATIENTS DIAGNOSED WITH CANCER FOLLOWING AN EMERGENCY PRESENTATION Dr Jennifer Yiallouros RCGP and CRUK workshop Brighton, March 2017 Acknowledgements Thames Valley Strategic Clinical
More informationGynaecological cancers. Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist
Gynaecological cancers Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist Gynaecological cancers Why do we need 2 week wait? Early/timely diagnosis of cancer Possibly less invasive treatment and
More informationReferral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography
Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography 2019 Released 2019 health.govt.nz Citation: Ministry of Health. 2019. Referral Criteria for Direct Access
More informationUrgent referral for suspected cancer in Scotland
270 Oncology Urgent referral for suspected cancer in Scotland Cancer is a common problem, but an individual GP may only see about seven to eight new cases of cancer per annum (although they will see many
More informationPrescribing Framework for Methotrexate for Immunosuppression in ADULTS
Hull & East Riding Prescribing Committee Prescribing Framework for Methotrexate for Immunosuppression in ADULTS Patient s Name:.. NHS Number: Patient s Address:... (Use addressograph sticker) GP s Name:...
More informationPrevention of Bowel Cancer: which patients do I send for colonoscopy?
Prevention of Bowel Cancer: which patients do I send for colonoscopy? Dr Chris Groves Consultant Gastroenterologist and Honorary Senior Lecturer St George s Hospital and Medical School Director, SW London
More informationMetastatic Spinal Cord Compression (MSCC) Clinical guidelines and pathway
Metastatic Spinal Cord Compression (MSCC) Clinical guidelines and pathway Version 2: May 2012 To be read in conjunction with NICE CG75 Developed by consensus by: Dr Peter Robson, Consultant Oncologist,
More informationInformation for people without an increased risk of bowel cancer. Family History of Bowel Cancer
Information for people without an increased risk of bowel cancer Family History of Bowel Cancer Bowel cancer in the family what does this mean for me? Bowel cancer is a fairly common type of cancer. Many
More informationCancer. University of Illinois at Chicago College of Nursing
Cancer University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Develop a basic understanding of cancer 2. Describe
More informationMultidisciplinary Diagnostic Centre (MDC) based pathways for patients with non-specific but concerning symptoms
Multidisciplinary Diagnostic Centre (MDC) based pathways for patients with non-specific but concerning symptoms Interim report May 2018 Version 2.4 Accelerate, Coordinate, Evaluate (ACE) Programme An early
More informationPancreatic Cancer. Stats, facts and how things can improve. Let s drive earlier diagnosis
Pancreatic Cancer Stats, facts and how things can improve Ali Stunt, Founder & Chief Executive Pancreatic Cancer Action (and 8 year survivor of pancreatic cancer) Let s drive earlier diagnosis The Pancreas
More informationVinorelbine (Oral) Oral Vinorelbine
Oral Vinorelbine Vinorelbine (Oral) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming
More informationRapid referral toolkit
Menu Introduction and help Cancer types and contacts Cancer services team Rapid referral toolkit Macmillan resources Acknowledgements www.macmillan.org.uk Macmillan Cancer Support, registered charity in
More informationFLU CLINICS 2012 This year, the surgery will be opening on Saturday 13 TH and 20 th October PLEASE NOTE:
GOODBYE Vicky one of our Receptionist s, who has now left us, we wish her luck in the future and hope she enjoys her new position in Helsby. FLU CLINICS 2012 This year, the surgery will be opening on Saturday
More informationReferral guidelines for suspected cancer
Referral guidelines for suspected cancer NICE guideline Second draft for consultation, September 2004 If you wish to comment on the recommendations, please make your comments on the full version of the
More informationA patient s guide to understanding. Cancer. Screening
A patient s guide to understanding Cancer Screening Contents 04 06 10 12 Cancer Screening Who Should Go For Cancer Screening 05 Nasopharyngeal Carcinoma Colorectal Cancer 08 Lung Cancer Liver Cancer Breast
More informationPancreatic Cancer. An overview for GPs. Let s drive earlier diagnosis. Pancreatic Cancer Action All Rights Reserved
Pancreatic Cancer An overview for GPs Pancreatic Cancer Action All Rights Reserved Pancreatic Cancer Action is a UK charity Registration no 1137689 Let s drive earlier diagnosis The Pancreas This image
More informationWhen to Refer for OGD and the Work Up of Upper GI Malignancies
When to Refer for OGD and the Work Up of Upper GI Malignancies Dr Hong Qiantai Registrar, Department of Surgery GP Forum 27 May 2017 38 year old female, non-smoker, BMI 29 Works as investment banker Presents
More informationBrain and Central Nervous System Cancers
Brain and Central Nervous System Cancers NICE guidance link: https://www.nice.org.uk/guidance/ta121 Clinical presentation of brain tumours History and Examination Consider immediate referral Management
More information1. What is fulvestrant?
Talk to our breast care nurses 0808 800 6000 1. What is fulvestrant? 2. How does fulvestrant work? 3. When might fulvestrant be prescribed? 4. How is fulvestrant given? 5. How long will I be given fulvestrant
More informationBowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care
Bowel cancer risk in the under 50s Greg Rubin Professor of General Practice and Primary Care Prevalence of GI problems in the consulting population Thompson et al, Gut 2000 Number of patients % of patients
More information6 UROLOGICAL CANCERS. 6.1 Key Points
6 UROLOGICAL CANCERS 6.1 Key Points Prostate Cancer Commonest cancer in males in Scotland Approximately 99% of cases occur in men aged > 50 years About 40% of cases present in men aged < 70 years when
More informationSOME USEFUL THINGS TO KNOW ABOUT HEAD AND NECK CANCER IN 2016
SOME USEFUL THINGS TO KNOW ABOUT HEAD AND NECK CANCER IN 2016 Ann Dingle Mid Cheshire Hospitals ENT Surgeon in a DGH with an interest in Head and Neck disease Cancer Lead Plan for today Facts and figures
More informationHealthcare Improvement Scotland First published May 2014
Scottish referral guidelines for suspected cancer: gynaecological; haematological; head and neck; brain and central nervous system; sarcomas and bone; children, teenagers and young adult cancers; and malignant
More informationChildhood Cancer. Dr Sarah Taaffe. Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session
Childhood Cancer Dr Sarah Taaffe Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session What I plan to cover in this session Background- Why this topic.. What types of cancer
More informationDr Greg Frazer. Respiratory Physician Christchurch Hospital Christchurch. 15:10-15:35 Primary and Secondary Healthcare Interface Supported by:
Dr Greg Frazer Respiratory Physician Christchurch Hospital Christchurch 15:10-15:35 Primary and Secondary Healthcare Interface Supported by: Primary and Secondary Healthcare Interface How Working Together
More informationLeeds: Early Diagnosis Project updates
Leeds: Early Diagnosis Project updates Cancer Cascade Event, 11 th May 2017 Joanna Bayton-Smith, Macmillan Leeds Cancer Strategy, Programme Manager Objectives: To provide overview of Leeds Cancer Strategy
More informationInformation leaflet for women with an increased lifetime risk of breast and ovarian cancer. Hereditary Breast and Ovarian Cancer (HBOC)
Information leaflet for women with an increased lifetime risk of breast and ovarian cancer Hereditary Breast and Ovarian Cancer (HBOC) What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast
More informationGynaecology Cancer Red Flags. Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017
Gynaecology Cancer Red Flags Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017 Gynaecological Cancers Endometrial Cancer Ovarian Cancer Cervical
More informationReferral guidelines for suspected cancer
Quick reference guide Issue date: June 2005 Referral guidelines for suspected cancer Clinical Guideline 27 Developed by the National Collaborating Centre for Primary Care Ordering information Copies of
More informationImproving diagnostic pathways for patients with vague symptoms
Improving diagnostic pathways for patients with vague symptoms Executive summary Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England, Cancer
More informationGemcitabine and Cisplatin (urology)
Gemcitabine and Cisplatin Gemcitabine and Cisplatin (urology) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce
More informationHEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia
HEFT Pathology Guideline GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia Produced by: Dr Charalampos Kartsios (Consultant Haematologist) and Muhammad Javed
More information9/13/2017. Highgate Private Hospital & Whittington Health NHS Trust. London Cancer Urology Guidelines for Target Referrals. Urological Cancer Groups
London Cancer Urology Guidelines for Target Referrals Mr Paul Erotocritou MBBS BSc MSc, MRCS, FRCS (Urol)Eng Highgate Private Hospital & Whittington Health NHS Trust Urological Cancer Groups 5 groups:
More informationGI cancer. Sharan Pobbathi Rumina Önaç
GI cancer Sharan Pobbathi Rumina Önaç Why is this relevant? One new case per year per GP York slightly below national average Contents/objectives To know the 2ww criteria and where to find them To be aware
More informationPhilippine Cancer Society Forum: Cancer can be cured!
Philippine Cancer Society Forum: Cancer can be cured! Throughout history, doctors and scientists have extensively studied Their researchers have not only yielded a wealth of information on the disease,
More informationSarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru
Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma
More informationNo. 2 - Persistent Pain or Discomfort in Any Body Area
See Your Doctor When Symptoms Occur, and Get Regular Checkups. Experts say that men could benefit greatly by being alert to certain cancer symptoms that indicate a trip to the doctor's office sooner rather
More informationSIGNS, SYMPTOMS AND SCREENING GUIDELINES
SIGNS, SYMPTOMS AND SCREENING GUIDELINES SIGNS AND SYMPTOMS You may think it s normal, but it could be a sign or symptom of an illness or cancer-related disease. If you are experiencing any of these signs
More informationAlectinib (Alecensa ) Alectinib (Alecensa )
Alectinib (Alecensa ) Alectinib (Alecensa ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary: for some people, treatment may reduce the risk of the cancer
More informationNICE Guidance. Suspected Cancer in Adults COLORECTAL (2WW)
NICE Guidance Suspected Cancer in Adults COLORECTAL (2WW) Date of Referral: Short date letter merged Name: Full Name DOB: Date of Birth NHS No NHS Number Attach this form to the e-referral within 24 hours
More informationCancer Facts for People Over 50
National Institute on Aging AgePage Cancer Facts for People Over 50 Cancer strikes people of all ages, but you are more likely to get cancer as you get older, even if no one in your family has ever had
More informationRAISING THE AWARENESS OF GYNAECOLOGICAL CANCER. Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015.
RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015. AIMS AND OBJECTIVES OF THE NEXT ½ HOUR. Brief overview of the different types of gynaecological cancers
More informationCANCER. Mrs. Davis Health Education
CANCER Mrs. Davis Health Education Cancer Terms: Tumors: Masses of useless tissue Benign: Non-cancerous Malignant: Cancerous Metastasis: Spread of cancer from the point where it originated to other parts
More informationPATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE
PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V3 MSCC Network
More informationIdentification and early detection of cancer patients in primary care Marcela Ewing MD, PhD Regionalt Cancercentrum väst Gothenburg Sweden
Identification and early detection of cancer patients in primary care Marcela Ewing MD, PhD Regionalt Cancercentrum väst Gothenburg Sweden 2018-11-16 Nordiskt möte Diagnostiska Centrum Cancer diagnosis
More informationTemozolomide Chemotherapy -
n The Leeds Teaching Hospitals NHS Trust Temozolomide Chemotherapy - instructions for taking during your radiotherapy for a primary brain tumour Information for patients This information is for patients
More informationBendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.
Bendamustine Bendamustine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,
More informationNEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.)
NEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.) TODAY'S DATE Your age DATE OF BIRTH YOUR NAME (Last) (First) (M.I.) REFERRED HERE BY YOUR PAST MEDICAL HISTORY (If YOU have
More informationMethotrexate for inflammatory bowel disease: what you need to know
Methotrexate for inflammatory bowel disease: what you need to know This leaflet aims to answer your questions about taking methotrexate for inflammatory bowel disease (IBD). If you have any questions or
More informationThe treatment is given every 3 weeks for 6 to 8 cycles.
R-CVP R-CVP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it
More informationOral cyclophosphamide in ovarian cancer
Oral cyclophosphamide in ovarian cancer Oral cyclophosphamide in ovarian cancer This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy
More informationNorthumbria Healthcare NHS Foundation Trust. Laparoscopic Cholecystectomy. Issued by the Department of Upper Gastrointestinal Surgery
Northumbria Healthcare NHS Foundation Trust Laparoscopic Cholecystectomy Issued by the Department of Upper Gastrointestinal Surgery Laparoscopic Cholecystectomy This leaflet explains why you have been
More informationGUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY
Position Statement produced by BSG, AUGIS and ACPGBI GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY Introduction In 2011 the Independent Practice
More informationBrentuximab vedotin. Brentuximab vedotin
Brentuximab vedotin Brentuximab vedotin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer
More informationVinblastine (Lymphoma)
Vinblastine (Lymphoma) Vinblastine (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the
More informationMyeloma Haematology and Transplant Unit CTD1
CTD1 Myeloma Haematology and Transplant Unit CTD1 This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of
More informationGemcitabine and carboplatin (Lung)
Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may
More informationAcute Oncology Induction Training Specification
Acute Oncology Induction Training Specification Author: Acute Oncology/Cancer of Unknown Primary Clinical Network Group (AO/CUP CNG) V. 2.0 Agreed: 30.11.2012 Reviewed: May 2015 Review : May 2016 MCCN
More informationNorth Trent Cancer Network. Referral Guidelines, Head & Neck Cancer (including Thyroid), for Primary Care Practitioners
North Trent Cancer Network Fulwood House Sheffield S10 3TH http://nww.barnsleyhealth.nhs.uk/pct/norcom/cancer/ Tel: 0114 2263436 Fax: 0114 2263407 Email: Kim.Fell@ntcn.nhs.uk Referral Guidelines, Head
More informationEpirubicin. Epirubicin
Epirubicin Epirubicin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for
More informationPatient Information Leaflet Number: CC 041 v2
Be Cancer Aware Patient Information Leaflet Number: CC 041 v2 Increase your awareness The sooner cancer is diagnosed the easier it can be treated. Being aware of when to seek advice can make a difference.
More informationBe cancer aware Patient Information
Be cancer aware Patient Information Author ID: AMK Leaflet Number: CC 041 Version: 2 Name of Leaflet: Be cancer aware Be Date cancer Produced: aware October 2017 Page 1 of 12 Review Date: October 2019
More information